YAP1 and colorectal carcinoma: Contrary to the clinical data globally supporting an unfavourable association between high YAP/TAZ expression and patient outcome, the issue as to whether YAP and/or TAZ activation may promote or suppress CRC based on animal studies remains highly controversial.